Advertisement

Indian Journal of Surgery

, Volume 70, Issue 3, pp 111–119 | Cite as

Sentinel lymphnode biopsy in early breast cancer using methylene blue dye and radioactive sulphur colloid — a single institution Indian experience

  • S. P. SomashekharEmail author
  • S. Zaveri Shabber
  • K. Udupa Venkatesh
  • K. Venkatachala
  • Parameshwaran
  • M. M. Vasan Thirumalai
Original Article

Abstract

Background

Axillary lymph node dissection is an established procedure in breast cancer staging. However, it is associated with unpleasant side effects. A promising alternative to assess axillary lymph node status in early breast cancer patients is Sentinel Lymph Node Biopsy (SLNB). Isosulfan blue has traditionally been the dye used to identify the Sentinel Lymph Node (SLN). This article is a validation study of SLNB using methylene blue dye and radioactive sulphur colloid in early breast cancer Indian patients.

Materials & Methods

With written informed consent, 100 patients with cytology or biospy proven carcinoma breast, clinical stage T1/ T2 N0 M0, underwent SLNB using combination of methylene blue dye & radioactive technetium 99m sulphur colloid as a part of validation study from June 2003 to February 2006. After validation study, from March 2006 to February 2007, 35 patients have undergone SLNB followed by complete axillary clearance in only those patients with SLNB being positive for metastases.

Results

In all 100 patients of the validation study SLN was identified. Total number of cases with positive axillary nodes was 27, out of which SLN was only positive node for metastases in 69% of cases. The overall sensitivity, specificity, positive predictive valve and negative predictive valve of SLNB 96.2%, 100%, 100% and 98.6% respectively with false negative rate of 3.7%. In subsequent 35 patients who underwent SLNB followed by complete axillary clearance, SLNs was identified in all the cases.

Conclusions

SLNB is effective in early breast cancer patients of Indian population. SLNB using combination of methylene blue dye and radio-active Tc99m sulphur colloid can stage the axilla with high accuracy & low risk of false negativity in early breast cancer patients.

Keywords

Sentinel lymph node biopsy Methylene blue dye Tc99m radioactive sulfur colloid Early breast cancer Indian patients 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cataliotti L, Distante V, Rontini M et al (1995) Role of axillary dissection in breast carcinoma. Chir Ital 47:23–31PubMedGoogle Scholar
  2. 2.
    Maunsell E, Brisson J, Deshenes L (1993) Arm problem and psychological distress after surgery for breast cancer. Can J Surg 36:315–320PubMedGoogle Scholar
  3. 3.
    Hlaudiuk M, Huchcroft S, Temple W, Schnurr BE (1992) Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 50: 47–52CrossRefGoogle Scholar
  4. 4.
    Keramopoulos A, Tsionou C, Minaretzious D et al (1993) Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 50:445–449PubMedGoogle Scholar
  5. 5.
    Hoe AL, Iven D, Royle GT, Taylor I (1992) Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 79:261–262PubMedCrossRefGoogle Scholar
  6. 6.
    Habal N, Giuliano AE, Morton DL (2001) The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer. Semin Oncol 28:41–52PubMedCrossRefGoogle Scholar
  7. 7.
    Wong J, Cagle L, Morton D (1991) Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 214:637–641PubMedCrossRefGoogle Scholar
  8. 8.
    Morton D, Wen DR, Cochran A (1992) Management of early stage melanoma by intra operative lymphatic mapping and selective lymphadenectomy: An alternative to routine elective lymph adenectomy or “watch and wait”. Surg Oncol Clin North Am 1:247–259Google Scholar
  9. 9.
    Schwartz G, Giuliano A, Veronesi U, and the Concensus Conference Committee (2002) Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer 94: 2542–2551PubMedCrossRefGoogle Scholar
  10. 10.
    Veronesi U, Luini A, Galimberti V et al (1990) Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 16:127–133PubMedGoogle Scholar
  11. 11.
    Veronesi U, Galimberti V, Zurrida S et al (1993) Prognostic significance of number and level of axillary node metastases in breast cancer. Breast 2:224–228CrossRefGoogle Scholar
  12. 12.
    Tsopelas C, Sutton R (2002) Why certain dyes are useful for localizing the sentinel lymph node. J Nucl Med 43: 1377–1382PubMedGoogle Scholar
  13. 13.
    Aihara T, Takatsuka Y (2003) Dye guided sentinel node biopsy revisited; validation and observational study from a single institute. Breast Cancer 10:254–259PubMedGoogle Scholar
  14. 14.
    Blessing WD, Stolier AJ, Teng SC et al (2002) A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg 184:341–345PubMedCrossRefGoogle Scholar
  15. 15.
    Simmons R, Thevarajah S, Brennan MB et al (2003) Methylene blue dye as an alternative to isosulfane blue dye for sentinel lymph node localization. Ann Surg Oncol 10:242–247PubMedCrossRefGoogle Scholar
  16. 16.
    Thevarajah S, Huston TL, Simmons RM et al (2005) A comparison of adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 189:236–239PubMedCrossRefGoogle Scholar
  17. 17.
    Eldrageely K, Vargas MP, Khalkali I et al (2004) Sentinel lymph node mapping of breast cancer: a case control study of methylene blue tracer compared to isosulfan blue. Am Surg 70:872–875PubMedGoogle Scholar
  18. 18.
    Nour A (2004) Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients. Breast J 10:388–391PubMedCrossRefGoogle Scholar
  19. 19.
    Golshan M, Nakhlis F (2006) Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J 12:428–430PubMedCrossRefGoogle Scholar
  20. 20.
    Watanabe T, Kimijima I, Ohtake T et al (2001) Sentinel node biopsy with technetium 99M colloidal rhenium sulphide in patients with breast cancer. Br J Surg 88:704–707PubMedCrossRefGoogle Scholar
  21. 21.
    Offodile R, Hoh C, Barsky SH et al (1998) Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabelled dextran. Cancer 82:1704–1708PubMedCrossRefGoogle Scholar
  22. 22.
    Hodgson N, Zabel P, Mattar AG et al (2001) A new radiocolloid for sentinel node detection in breast cancer. Ann Surg Oncol 8:133–137PubMedCrossRefGoogle Scholar
  23. 23.
    Lloyd LR, Wesen CA, Mc Callum S (2002) An analysis of filtration and volume of radionucleotide in sentinel lymph node biopsy in breast cancer patients. Am Surg 68:373–375; discussion 375–376PubMedGoogle Scholar
  24. 24.
    Martin RC 2nd, Edwards MJ, Wong SL et al (2000) Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer; results of a multi-institutional study. For the university of Louis ville breast cancer study group. Surgery 128:139–144PubMedCrossRefGoogle Scholar
  25. 25.
    Linehan DC, Hill AD, Tran KN et al (1999) Sentinel lymph node biopsy in breast cancer: unfiltered radio isotope is superior to filtered. J Am Coll Surg 188:377–381PubMedCrossRefGoogle Scholar
  26. 26.
    Code HS 3rd, Hill AD, Tran K N et al (1999) Credintialing for breast lymphatic mapping: how many cases are enough? Ann Surg 229:723–726; discussion 726–728CrossRefGoogle Scholar
  27. 27.
    Alazraki N, Styblo T, Grant S et al (2000) Sentinel node staging of early breast cancer using lymphoscintigrapy and the intra operative gamma detecting probe. Semin Nucl Med 30:55–64CrossRefGoogle Scholar
  28. 28.
    Krag D, Harlow S, Weaver D et al (2001) Radio labeled sentinel node biopsy: collaborative trial with N C I. World J Surg 25:823–828PubMedCrossRefGoogle Scholar
  29. 29.
    Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in patient with breast cancer. JAMA 276:1818–1822PubMedCrossRefGoogle Scholar
  30. 30.
    O’Hea BJ, Hill AD, EL-Shirbiny AM et al (1998) Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan Kettering Cancer Center. J Am Coll Surg 186:423–427PubMedCrossRefGoogle Scholar
  31. 31.
    Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 339:941–946PubMedCrossRefGoogle Scholar
  32. 32.
    Snider H, Dowlatshahi K, Fan M et al (1998) Sentinel node biopsy in the staging of breast cancer. Am J Surg 176: 305–310PubMedCrossRefGoogle Scholar
  33. 33.
    van der Ent F, Kengen R, van der Pol H et al (1999) Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 25: 24–29PubMedCrossRefGoogle Scholar
  34. 34.
    Moffat FL, Seza AG, Sittler SY et al (1999) Unfiltered sulphur colloid and sentinel node biopsy for breast cancer; technical and kinetic considerations. Ann Surg Oncol 6: 746–755PubMedCrossRefGoogle Scholar
  35. 35.
    McMasters KM, Wong SL, Tuttle TM et al (2000) Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 231:724–731PubMedCrossRefGoogle Scholar
  36. 36.
    Burak WE Jr, Walker MJ, Yee LD et al (1999) Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 177:445–449PubMedCrossRefGoogle Scholar
  37. 37.
    De Cicco C, Cremonesi M, Luini A et al (1998) Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 39:2080–2084PubMedGoogle Scholar
  38. 38.
    McMasters KM, Wong SL, Martin RC 2nd et al (2001) Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel node biopsy: results of a multi-institutional study. Ann Surg 233:676–687PubMedCrossRefGoogle Scholar
  39. 39.
    D’Eredita G, Ferrarese F, Cecere V et al (2003) Subareolar injection may be more accurate than other techniques for sentinel lymphnode biopsy in breast cancer. Ann Surg Oncol 10:942–947PubMedCrossRefGoogle Scholar
  40. 40.
    Pelosi E, Bello M, Giors M et al (2004) Sentinel lymph node detection in patients with early stage breast cancers: comparison of periareolar and subdermal / peritumoral injection techniques. J Nucl Med 45:220–225PubMedGoogle Scholar
  41. 41.
    Klimberg VS, Rubio IT, Henry R et al (1999) Subareolar versus peritumoral injection for location of sentinel lymph node. Ann Surg 229:860–864; discussion 864–865PubMedCrossRefGoogle Scholar
  42. 42.
    Bauer TW, Spitz FR, Callans LS et al (2002) Subareolar and pertumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 9:169–176PubMedCrossRefGoogle Scholar
  43. 43.
    Shimazu K, Tamaki Y, Taguchi T et al (2003) Lymphoscintigraphy visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with braest cancer. Ann Surg 237:390–398PubMedCrossRefGoogle Scholar
  44. 44.
    Dupont EL, Salud CJ, Peltz ES et al (2001) Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 182:321–324PubMedCrossRefGoogle Scholar
  45. 45.
    Tanis PJ, Nieweg OE, Valdes Olmos RA et al (2002) Impact of non axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer 87: 705–710PubMedCrossRefGoogle Scholar
  46. 46.
    Freedman GM, Fowble BL, Nicolaou N et al (2000) Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 46: 805–814PubMedGoogle Scholar
  47. 47.
    Valdes-Olmos RA, Jansen L, Hoefnagel CA et al (2000) Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med 41:1500–1506PubMedGoogle Scholar
  48. 48.
    Albo D, Wayne JD, Hunt KK et al (2001) Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 182:393–398PubMedCrossRefGoogle Scholar
  49. 49.
    Montgomery LL, Thorne AC, Van Zee KJ et al (2002) Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Aalg 95:385–388CrossRefGoogle Scholar
  50. 50.
    Koivusalo AM, Von Smitten K, Lindgren L (2002) Sentinel node mapping affects intraoperative pulse oximetric recordings during breast cancer surgery. Acta Anaesthesiol Scand 46:411–414PubMedCrossRefGoogle Scholar
  51. 51.
    Heinle E, Burdumy T, Recaberan J (2003) Factitious oxygen desaturation after isosulfan blue injection. Am Surg 69: 899–901PubMedGoogle Scholar
  52. 52.
    Stradling B, Aranha G, Gabram S (2002) Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 184:350–352PubMedCrossRefGoogle Scholar
  53. 53.
    Salhab M, Al Sarakbi W, Mokbel K (2005) Skin and fat necrosis of the breast following methylene blue dye injection for sentinel lymph node biopsy in a patient with breast cancer. Int Semin Surg Oncol 28:26CrossRefGoogle Scholar
  54. 54.
    Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–401PubMedCrossRefGoogle Scholar
  55. 55.
    Zurida S, Galimberti V, Orvieto E et al (2000) Radioguided sentinel node biopsy to avoid axillary dissection in breast cancer. Ann Surg Oncol 7:28–31CrossRefGoogle Scholar
  56. 56.
    Rahusen FD, Pijpers R, Van Diest PJ et al (2000) The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery 128:6–15PubMedCrossRefGoogle Scholar
  57. 57.
    Motomura K, Inaji H, Komoike Y et al (2001) Combination technique is superior to dye alone in identification of sentinel node in breast cancer patients. J Surg Oncol 76: 95–99PubMedCrossRefGoogle Scholar
  58. 58.
    Cserni G, Rajtar M, Boross G et al (2002) Comparison of vital dye guided lymphatic mapping and dye plus gamma probe guided sentinel node biopsy in breast cancer. World J Surg 26:592–597PubMedCrossRefGoogle Scholar
  59. 59.
    McMasters K, Tuttle T, Carlson D et al (2000) Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary lymph node dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18:2560–2566PubMedGoogle Scholar
  60. 60.
    Cox CE, Pendas S, Cox JM et al (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645–651; discussion 651–653PubMedCrossRefGoogle Scholar
  61. 61.
    Paganelli G, De Cicco C, Cremonesi M et al (1998) Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 42:49–53PubMedGoogle Scholar
  62. 62.
    Veronesi U, Paganelli G, Viale G et al (1999) Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91:368–373PubMedCrossRefGoogle Scholar
  63. 63.
    Zervos EE, Burak WE Jr (2000) Lymphatic mapping for breast cancer: experience at The Ohio State University. Breast Cancer 7:195–200PubMedCrossRefGoogle Scholar
  64. 64.
    Villa G, Gipponi M, Buffoni F et al (2000) Localisation of sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye and intra operative gamma probe. Tumori 86:297–299PubMedGoogle Scholar
  65. 65.
    Noguchi M, Motumura K, Imoto S et al (2000) A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63: 31–40PubMedCrossRefGoogle Scholar
  66. 66.
    Yu JC, Hsu GC, Liu YC et al (2002) Sentinel lymph node biopsy in early breast cancer in Taiwan. World J Surg 26: 1365–1369PubMedCrossRefGoogle Scholar
  67. 67.
    Nano MT, Kollias J, Farshid G et al (2002) Clinical impact of false negative sentinel lymph node biopsy in primary breast cancer. Br J Surg 89:1430–1434PubMedCrossRefGoogle Scholar
  68. 68.
    Yong WS, Wong CY, Lee JS et al (2003) Single institution’s initial experience with sentinel lymph node biopsy in breast cancer patients. ANZ J Surg 73:416–421PubMedCrossRefGoogle Scholar
  69. 69.
    Fortunato L, Farina M, Alessi G et al (2003) Sentinel lymph node biopsy in breast cancer: experience of four years. Chir Ital 55:669–680PubMedGoogle Scholar
  70. 70.
    Bobin JY, Spirito C, Isaac S et al (2000) Lymph node mapping and axilllary sentinel lymph node biopsy in 243 invasive breast cancers with no palpable nodes. The South Lyon Hospital Center experience. Ann Chir 125: 861–870PubMedCrossRefGoogle Scholar
  71. 71.
    Tafra L, Lannin DR, Swanson MS et al (2001) Multicenter trial of sentinel node biopsy for breast cancer using both tecnetium sulfur colloid and isosulfan blue dye. Ann Surg 233:51–59PubMedCrossRefGoogle Scholar
  72. 72.
    Shivers S, Cox C, Leight G et al (2002) Final results of the Department of Defense multicenter breast lymphatic mapping trial. Ann Surg Oncol 9:248–255PubMedCrossRefGoogle Scholar
  73. 73.
    Pramar V, Badwe R, Mittra I et al (2003) Sentinel node biopsy in operable breast cancer. Indian J Surg 65: 361–365Google Scholar
  74. 74.
    Deo S, Samaiya A, Jain P et al (2004) Sentinel lymph node assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study. Asian J Surg 27:294–298PubMedGoogle Scholar
  75. 75.
    American Society of Breast Diseases: Rapid response panel on SLNB. Advisor Spring 2003; 8:10Google Scholar
  76. 76.
    Euhus DM, Peters GN, Leitch AM et al (2002) Validating the performance of the mammary sentinel node team. J Surg Oncol 79:209–215PubMedCrossRefGoogle Scholar
  77. 77.
    Guidelines from the American Society of Breast Surgeons available online at www.breastsurgeons.org/officialstmts/sentinel.html (accessed September 13th 2005)Google Scholar
  78. 78.
    Clarke D, Khonji NI, Mansel RE (2001) Sentinel node biopsy in breast cancer: ALMANAC Trial. World J Surg 25: 819–822PubMedCrossRefGoogle Scholar
  79. 79.
    Harlow SP, Krage DN (2001) Sentinel lymph node — why study it:implications of B-32 study. Semin Surg Oncol 20: 224–229PubMedCrossRefGoogle Scholar
  80. 80.
    Giuliano AE, Hiagh PI, Brennan MB et al (2000) Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node negative breast cancer. J Clin Oncol 18: 2553–2559PubMedGoogle Scholar

Copyright information

© Association of Surgeons of India 2008

Authors and Affiliations

  • S. P. Somashekhar
    • 1
    Email author
  • S. Zaveri Shabber
    • 1
  • K. Udupa Venkatesh
    • 1
  • K. Venkatachala
    • 1
  • Parameshwaran
    • 2
  • M. M. Vasan Thirumalai
    • 3
  1. 1.Department of Surgical Oncology, Manipal Comprehensive Cancer CentreManipal HospitalBangaloreIndia
  2. 2.Deparment of Nuclear MedicineManipal HospitalBangaloreIndia
  3. 3.Department of General SurgeryManipal HospitalBangaloreIndia

Personalised recommendations